🗂️
Archived grant — no longer open
This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.
grant
Evaluating a Multilevel Communication Campaign to Increase HIV Vaccine Trial Enrollment
Organization FRED HUTCHINSON CANCER CENTERLocation SEATTLE, UNITED STATESPosted 19 May 2023Deadline 1 Apr 2025 ⚠️
NIHUS FederalResearch GrantFY20252019-nCoV vaccineAIDS VirusAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAddressAdvertisingAffectAwarenessBIPOCBehavioralBlack, Indigenous, People of ColorCOVID crisisCOVID epidemicCOVID pandemicCOVID-19COVID-19 Prevention NetworkCOVID-19 crisisCOVID-19 epidemicCOVID-19 eraCOVID-19 global health crisisCOVID-19 global pandemicCOVID-19 health crisisCOVID-19 pandemicCOVID-19 periodCOVID-19 public health crisisCOVID-19 vaccineCOVID-19 yearsCV-19ClassificationCoVPNCollaborationsCommentCommentaryCommunicationCommunitiesCoronavirus Infectious Disease 2019CurriculumDataDevelopmentDissemination and ImplementationE-MailEditorial CommentEducational CurriculumEffectivenessElectronic MailEmailEnrollmentFacebookFocus GroupsFundingFutureGeneral TaxonomyGoalsGovernmentHIVHIV Vaccine Trials NetworkHIV vaccineHIV/AIDS VaccinesHVTNHealthHealth ServicesHuman Immunodeficiency VirusesInstagramInternationalInterruptionInvestigatorsKnowledgeLAV-HTLV-IIILGBTQLesbian Gay Bi-sexual Transgender QueerLesbian Gay Bisexual Transgender QueerLong-term Follow-upLymphadenopathy-Associated VirusMarketingMeasuresMedia CampaignMedical ResearchMisinformationModelingOutcomeParticipantPatient RecruitmentsPerformancePhasePhase 3 Clinical TrialsPhase III Clinical TrialsPopulation HeterogeneityPositionPositioning AttributePreventiveProtocolProtocols documentationPublished CommentRegistriesResearchResearch PersonnelResearchersSARS-CoV-2 epidemicSARS-CoV-2 global health crisisSARS-CoV-2 global pandemicSARS-CoV-2 pandemicSARS-CoV-2 vaccineSARS-coronavirus-2 epidemicSARS-coronavirus-2 pandemicSARS-coronavirus-2 vaccineSeriesSevere Acute Respiratory Syndrome CoV 2 epidemicSevere Acute Respiratory Syndrome CoV 2 pandemicSevere Acute Respiratory Syndrome CoV 2 vaccineSevere acute respiratory syndrome coronavirus 2 epidemicSevere acute respiratory syndrome coronavirus 2 pandemicSevere acute respiratory syndrome coronavirus 2 vaccineSurvey InstrumentSurveysSystematicsTaxonomyTestingTimeTrainingTrustTwitterUnited StatesVaccine Clinical TrialVaccinesViewpointVirus-HIVVisitWorkclinical research siteclinical siteclinical trainingcombatcommunity based participatory researchcommunity engagementcommunity led researchcommunity marginalizationcommunity participatory researchcommunity partnered participatory researchcommunity partnershipcoronavirus disease 2019coronavirus disease 2019 crisiscoronavirus disease 2019 epidemiccoronavirus disease 2019 global health crisiscoronavirus disease 2019 global pandemiccoronavirus disease 2019 health crisiscoronavirus disease 2019 pandemiccoronavirus disease 2019 prevention networkcoronavirus disease 2019 public health crisiscoronavirus disease 2019 vaccinecoronavirus disease crisiscoronavirus disease epidemiccoronavirus disease pandemiccoronavirus disease-19coronavirus disease-19 global pandemiccoronavirus disease-19 pandemiccoronavirus disease-19 vaccinecoronavirus infectious disease-19designdesigningdevelopmentaldiverse populationsdiversity, equity, and inclusivenessearly phase trialefficacy testingelectronic communicationeligible participantengagement with communitiesenrollequity, diversity, and inclusionevidence baseexperienceforginghealth communicationhesitant to vaccinationheterogeneous populationhuman immunodeficiency virus vaccineimplementation researchimprovedinnovateinnovationinnovativelesson planslong-term followupmarginalized communitymultidisciplinarynCoV vaccinenCoV-19 vaccinenCoV19 vaccineoutreachparticipant enrollmentparticipant recruitmentparticipatory action researchpatient enrollmentphase III protocolpopulation diversityprimary outcomeprogramsrecruitseropositivesevere acute respiratory syndrome coronavirus 2 global health crisissevere acute respiratory syndrome coronavirus 2 global pandemicsocial media platformsocial platformsocial stigmastigmatrend analysistrial enrollmenttrustworthinessvaccination hesitancyvaccination studyvaccination trialvaccine against 2019-nCovvaccine against COVID-19vaccine against SARS-CoV-2vaccine against SARS-coronavirus-2vaccine against Severe Acute Respiratory Syndrome CoV 2vaccine against Severe acute respiratory syndrome coronavirus 2vaccine candidates against SARS-CoV-2vaccine for novel coronavirusvaccine hesitancyvaccine hesitantvaccine studyvaccine trialvaccines preventing COVIDvaccines to prevent COVIDvirtualweb sitewebsite
Applications closed.
Description preview
Project Summary/Abstract
The HIV Vaccine Trials Network (HVTN) has experienced significant challenges recruiting
participants in early-stage HIV vaccine clinical trials. Formidable barriers to participation
in HVTN preventive HIV early phase trials, including lack of HIV public urgency, numerous
study visits, long-term follow-up, vaccine induced…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click